Literature DB >> 28831542

[Importance of imaging diagnostics and EEG for differential diagnosis of epileptic seizures].

C Vollmar1, S Noachtar2.   

Abstract

Electroencephalography (EEG) and neuroimaging are the two most crucial diagnostic methods for epilepsy. The EEG represents the only specific method to detect epileptogenicity of a brain lesion. The EEG shows some syndrome-specific alterations, helps to make therapeutic decisions and allows prognosis about the disease. Neuroimaging in epilepsy includes magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and single-photon emission computed tomography (SPECT). Neuroimaging is crucial to clarify the underlying etiology and to localize the epileptogenic zone and has contributed to expanding the spectrum of patients where epilepsy surgery can be provided. Both EEG and neuroimaging are valuable methods in the hands of experienced epileptologists but both can also be misdiagnosed and lead to a wrong diagnosis and treatment decisions. This review discusses the contribution of both methods, their potential role and limitations and shows typical examples of wrong interpretation.

Entities:  

Keywords:  Computed tomography; Epilepsy diagnostics; Magnetic resonance imaging; Positron emission tomography; Single-photon emission computed tomography

Mesh:

Year:  2017        PMID: 28831542     DOI: 10.1007/s00115-017-0402-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

1.  Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci.

Authors:  T J O'Brien; E L So; B P Mullan; M F Hauser; B H Brinkmann; C R Jack; G D Cascino; F B Meyer; F W Sharbrough
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

2.  [Neuroimaging of epilepsies].

Authors:  C Vollmar; C la Fougère
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

3.  Ambulatory EEG recordings in epileptic and nonepileptic children.

Authors:  M J Aminoff; D S Goodin; B O Berg; M N Compton
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

4.  Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy.

Authors:  J Von Oertzen; H Urbach; S Jungbluth; M Kurthen; M Reuber; G Fernández; C E Elger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

5.  Latency of interictal epileptiform discharges in long-term EEG recordings in epilepsy patients.

Authors:  Konrad J Werhahn; Elisabeth Hartl; Kristin Hamann; Markus Breimhorst; Soheyl Noachtar
Journal:  Seizure       Date:  2015-03-24       Impact factor: 3.184

Review 6.  The role of FDG-PET, ictal SPECT, and MEG in the epilepsy surgery evaluation.

Authors:  Robert C Knowlton
Journal:  Epilepsy Behav       Date:  2006-01-10       Impact factor: 2.937

Review 7.  Clinical MRI in children and adults with focal epilepsy: a critical review.

Authors:  Friedrich G Woermann; Christian Vollmar
Journal:  Epilepsy Behav       Date:  2009-02-21       Impact factor: 2.937

8.  Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: an operational curve.

Authors:  M Salinsky; R Kanter; R M Dasheiff
Journal:  Epilepsia       Date:  1987 Jul-Aug       Impact factor: 5.864

Review 9.  ILAE official report: a practical clinical definition of epilepsy.

Authors:  Robert S Fisher; Carlos Acevedo; Alexis Arzimanoglou; Alicia Bogacz; J Helen Cross; Christian E Elger; Jerome Engel; Lars Forsgren; Jacqueline A French; Mike Glynn; Dale C Hesdorffer; B I Lee; Gary W Mathern; Solomon L Moshé; Emilio Perucca; Ingrid E Scheffer; Torbjörn Tomson; Masako Watanabe; Samuel Wiebe
Journal:  Epilepsia       Date:  2014-04-14       Impact factor: 5.864

10.  Subcortical cystic lesions within the anterior superior temporal gyrus: a newly recognized characteristic location for dilated perivascular spaces.

Authors:  S Rawal; S E Croul; R A Willinsky; M Tymianski; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-14       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.